Ottilia Balazs
30-32 Gyömrői Street
Budapest, BU 1103, Hungary
Budapest, BU 1103, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The Discovery of RGH-706, a Highly Efficacious MCH1 Receptor Antagonist, for the Treatment of Obesity and Insatiable Hunger.
Journal: Journal of medicinal chemistry
Published: January 22, 2026
Discovery of Novel Steroid-Based Histamine H3 Receptor Antagonists/Inverse Agonists.
Journal: Journal of medicinal chemistry
Published: February 23, 2024
Optimization of Novel α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulators and the Discovery of a Preclinical Development Candidate Molecule (RGH-560).
Journal: Journal of medicinal chemistry
Published: November 21, 2023
Convergent cross-species pro-cognitive effects of RGH-235, a new potent and selective histamine H3 receptor antagonist/inverse agonist.
Journal: European journal of pharmacology
Published: May 07, 2021
HTS-based discovery and optimization of novel positive allosteric modulators of the α7 nicotinic acetylcholine receptor.
Journal: European journal of medicinal chemistry
Published: February 26, 2021
Cariprazine modulates sleep architecture in rats.
Journal: Journal of psychopharmacology (Oxford, England)
Published: January 07, 2021
Discovery of novel positive allosteric modulators of the α7 nicotinic acetylcholine receptor: Scaffold hopping approach.
Journal: European journal of medicinal chemistry
Published: October 08, 2020
Discovery of novel steroidal histamine H3 receptor antagonists/inverse agonists. Part 2. Versatile steroidal carboxamide derivatives.
Journal: Bioorganic & medicinal chemistry letters
Published: May 22, 2019
Preclinical pharmacodynamic and pharmacokinetic characterization of the major metabolites of cariprazine.
Journal: Drug design, development and therapy
Published: September 26, 2018
Discovery of novel steroidal histamine H3 receptor antagonists/inverse agonists.
Journal: Bioorganic & medicinal chemistry letters
Published: July 03, 2017
Discovery and Preclinical Characterization of 3-((4-(4-Chlorophenyl)-7-fluoroquinoline-3-yl)sulfonyl)benzonitrile, a Novel Non-acetylenic Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulator for Psychiatric Indications.
Journal: Journal of medicinal chemistry
Published: February 18, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026